Faculty, Staff and Student Publications
Publication Date
5-1-2023
Journal
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
DOI
10.1016/j.bbcan.2023.188892
PMID
37004960
Abstract
Vestigial-like 1 (VGLL1) is a recently discovered driver of proliferation and invasion that is expressed in many aggressive human malignancies and is strongly associated with poor prognosis. The VGLL1 gene encodes for a co-transcriptional activator that shows intriguing structural similarity to key activators in the hippo pathway, providing important clues to its functional role. VGLL1 binds to TEAD transcription factors in an analogous fashion to YAP1 but appears to activate a distinct set of downstream gene targets. In mammals, VGLL1 expression is found almost exclusively in placental trophoblasts, cells that share many hallmarks of cancer. Due to its role as a driver of tumor progression, VGLL1 has become a target of interest for potential anticancer therapies. In this review, we discuss VGLL1 from an evolutionary perspective, contrast its role in placental and tumor development, summarize the current knowledge of how signaling pathways can modulate VGLL1 function, and discuss potential approaches for targeting VGLL1 therapeutically.
Keywords
Animals, Female, Humans, Pregnancy, DNA-Binding Proteins, Placenta, Transcription Factors, TEA Domain Transcription Factors, Neoplasms, Mammals
Published Open-Access
yes
Recommended Citation
Sonnemann, Heather M; Pazdrak, Barbara; Antunes, Dinler A; et al., "Vestigial-Like 1 (VGLL1): An Ancient Co-Transcriptional Activator Linking Wing, Placenta, and Tumor Development" (2023). Faculty, Staff and Student Publications. 4777.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4777
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons